S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.39 (+0.42%)
META   502.32 (+2.49%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.65 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.78 (+0.52%)
AMD   202.64 (+5.25%)
BABA   74.62 (+0.80%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.39 (+0.42%)
META   502.32 (+2.49%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.65 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.78 (+0.52%)
AMD   202.64 (+5.25%)
BABA   74.62 (+0.80%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.39 (+0.42%)
META   502.32 (+2.49%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.65 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.78 (+0.52%)
AMD   202.64 (+5.25%)
BABA   74.62 (+0.80%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.39 (+0.42%)
META   502.32 (+2.49%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.65 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.78 (+0.52%)
AMD   202.64 (+5.25%)
BABA   74.62 (+0.80%)
T   16.98 (+0.30%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.65 (+1.12%)
DIS   111.95 (+0.33%)
AMC   4.36 (+0.93%)
PFE   26.59 (+0.11%)
PYPL   60.54 (+0.33%)
XOM   105.84 (+1.26%)

Alphatec (ATEC) Competitors

$13.42
-0.01 (-0.07%)
(As of 04:00 PM ET)

ATEC vs. ATRC, MDXG, IART, OSUR, OFIX, TCMD, GMED, TNDM, NVCR, and PRCT

Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include AtriCure (ATRC), MiMedx Group (MDXG), Integra LifeSciences (IART), OraSure Technologies (OSUR), Orthofix Medical (OFIX), Tactile Systems Technology (TCMD), Globus Medical (GMED), Tandem Diabetes Care (TNDM), NovoCure (NVCR), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical" sector.

Alphatec vs.

Alphatec (NASDAQ:ATEC) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, community ranking, dividends, profitability and analyst recommendations.

Alphatec has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, AtriCure has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500.

AtriCure has lower revenue, but higher earnings than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$482.26M3.84-$152.15M-$1.55-8.66
AtriCure$399.25M4.32-$30.44M-$0.66-54.97

Alphatec presently has a consensus target price of $22.75, suggesting a potential upside of 69.14%. AtriCure has a consensus target price of $55.57, suggesting a potential upside of 54.92%. Given Alphatec's higher possible upside, research analysts clearly believe Alphatec is more favorable than AtriCure.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
AtriCure
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

AtriCure received 234 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 68.96% of users gave AtriCure an outperform vote while only 56.20% of users gave Alphatec an outperform vote.

CompanyUnderperformOutperform
AlphatecOutperform Votes
308
56.20%
Underperform Votes
240
43.80%
AtriCureOutperform Votes
542
68.96%
Underperform Votes
244
31.04%

67.2% of Alphatec shares are held by institutional investors. Comparatively, 94.3% of AtriCure shares are held by institutional investors. 29.1% of Alphatec shares are held by insiders. Comparatively, 3.0% of AtriCure shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

AtriCure has a net margin of -7.62% compared to Alphatec's net margin of -38.70%. Alphatec's return on equity of 0.00% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-38.70% N/A -27.93%
AtriCure -7.62%-7.55%-5.83%

In the previous week, Alphatec had 21 more articles in the media than AtriCure. MarketBeat recorded 27 mentions for Alphatec and 6 mentions for AtriCure. AtriCure's average media sentiment score of 0.65 beat Alphatec's score of 0.22 indicating that AtriCure is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
7 Very Positive mention(s)
5 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
AtriCure
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

AtriCure beats Alphatec on 9 of the 17 factors compared between the two stocks.


Get Alphatec News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEC vs. The Competition

MetricAlphatecSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.85B$3.77B$5.00B$7.60B
Dividend YieldN/A2.07%2.88%3.87%
P/E Ratio-8.6614.66219.2616.72
Price / Sales3.8428.203,026.5374.93
Price / CashN/A25.3596.7554.95
Price / Book23.544.134.554.71
Net Income-$152.15M$19.63M$114.42M$211.39M
7 Day Performance-12.12%2.72%5.43%3.23%
1 Month Performance-19.54%3.39%10.09%6.07%
1 Year Performance-11.07%1.75%13.58%9.40%

Alphatec Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATRC
AtriCure
2.2665 of 5 stars
$34.19
+3.2%
$55.57
+62.5%
-9.2%$1.63B$399.24M-51.801,200Short Interest ↑
MDXG
MiMedx Group
3.7595 of 5 stars
$8.40
+1.7%
$11.67
+38.9%
+69.6%$977.59M$267.84M-420.00867Analyst Report
Analyst Revision
News Coverage
IART
Integra LifeSciences
4.0726 of 5 stars
$44.27
+0.3%
$46.22
+4.4%
-33.6%$3.46B$1.56B36.593,722Earnings Report
Analyst Downgrade
Short Interest ↑
News Coverage
OSUR
OraSure Technologies
3.4628 of 5 stars
$7.03
+0.3%
$6.33
-9.9%
+14.0%$516.59M$452.67M10.65840Earnings Report
News Coverage
OFIX
Orthofix Medical
0.3845 of 5 stars
$13.67
+1.6%
$14.00
+2.4%
-36.6%$502.51M$460.71M-3.511,092Upcoming Earnings
News Coverage
TCMD
Tactile Systems Technology
4.1391 of 5 stars
$15.97
+2.9%
$29.33
+83.7%
+5.5%$376.89M$274.42M13.31982Gap Down
GMED
Globus Medical
4.596 of 5 stars
$56.43
+0.9%
$67.13
+19.0%
-7.5%$7.78B$1.02B48.235,000Short Interest ↑
TNDM
Tandem Diabetes Care
3.7997 of 5 stars
$27.34
-5.3%
$35.33
+29.2%
-25.7%$1.79B$747.72M-7.952,400Positive News
NVCR
NovoCure
3.5408 of 5 stars
$16.30
+9.4%
$38.00
+133.1%
-80.1%$1.75B$509.34M-8.361,320
PRCT
PROCEPT BioRobotics
1.0133 of 5 stars
$50.75
+3.9%
$44.00
-13.3%
+29.1%$2.56B$75.01M-21.78428Earnings Report
Analyst Report
Analyst Revision
News Coverage

Related Companies and Tools

This page (NASDAQ:ATEC) was last updated on 3/1/2024 by MarketBeat.com Staff